Skip to main content
Figure 1 | Lipids in Health and Disease

Figure 1

From: Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency

Figure 1

Percent change in lipid and hs-CRP levels after 6 weeks of treatment in patients treated with low-potency statins* at baseline. *Low potency stratum included: simvastatin 20 mg, pravastatin 40 mg, fluvastatin 80 mg, atorvastatin 10 mg. †Presented as median values. Apo B = apolipoprotein B; E = ezetimibe; hs-CRP = high-sensitivity C-reactive protein; LDL-C = low-density lipoprotein cholesterol; HDL-C = high-density lipoprotein cholesterol; R = rosuvastatin; S = simvastatin; TG = triglycerides; Total C = total cholesterol

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X